Vivakor, Inc.
VIVK Nasdaq Refuse Systems Financials FY2020βFY2025
What Vivakor, Inc. does
No business description yet.
- Legal name
- Vivakor, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Apr 15, 2026
- Accession Β· CIK
- 0001829126-26-003530
0001450704
Revenue and margins
Vivakor, Inc. had $104M of revenue in fiscal 2025, up 16.3% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Vivakor, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 138.1%.
Balance sheet
Cash, debt and the ratios that show how comfortably Vivakor, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.3M | $3.1M | $0.7M | $0.7M | $0.3M |
| Current ratio | 0.7x | 0.7x | 0.1x | 0.1x | 0.1x |
| Quick ratio | 0.7x | 0.7x | 0.1x | 0.1x | 0.1x |
| Total assets | $47.7M | $76.3M | $71.2M | $241M | $113M |
| Total liabilities | $20.2M | $49.3M | $54.0M | $126M | $76.3M |
| Shareholders' equity | $22.5M | $18.9M | $17.2M | $119M | $41.3M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 1 / 7 | 3 / 7 | 3 / 7 | 5 / 8 | 4 / 8 |
| Accruals ratio | β2.6% | β9.7% | β26.0% | β13.6% | β18.0% | β53.3% |
| Altman Z'' | β1.69 | β2.53 | β4.28 | β6.49 | β3.59 | β12.16 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $1.5M | $1.1M | $28.1M | $59.3M | $89.8M | $104M |
| Gross profit | $0.1M | $0.0M | $2.9M | $5.0M | $10.2M | $37.7M |
| Operating income | β$4.8M | β$6.9M | β$22.7M | β$6.3M | β$22.0M | β$63.8M |
| Pretax income | β | β$8.3M | β$24.7M | β$10.7M | β$26.2M | β$110M |
| Income tax | $0.5M | β$1.1M | β$4.4M | $0.1M | $0.1M | $0.1M |
| Net income | β$2.9M | β$7.3M | β$20.2M | β$10.8M | β$26.4M | β$110M |
| Net income to common | β$2.4M | β$5.5M | β$19.4M | β$10.7M | β$23.0M | β$115M |
| Diluted EPS | β | β | β | β$0.56 | β$151.32 | β$318.01 |
| Diluted shares | β | β | β | 0.02B | 0.00B | 0.00B |
| Cash flow | ||||||
| Cash from operations | β$1.8M | β$2.9M | β$4.1M | β$0.8M | $1.8M | β$15.8M |
| Capital expenditure | $1.2M | $4.2M | $2.5M | $3.3M | β | β |
| Free cash flow | β$3.0M | β$7.1M | β$6.6M | β$4.1M | β | β |
| Depreciation and amortization | $1.6M | $1.5M | $3.0M | $3.9M | $11.4M | $18.0M |
| Stock-based compensation | $0.1M | $0.4M | $2.6M | $1.6M | $2.6M | $1.5M |
| Balance sheet | ||||||
| Cash and short-term investments | $0.3M | $1.3M | $3.1M | $0.7M | $0.7M | $0.3M |
| Finance lease liabilities | β | $0.0M | $3.3M | $2.8M | $9.4M | $8.7M |
| Deposits | $0.0M | $0.0M | $0.0M | β | β | β |
| Current assets | $6.2M | $5.2M | $9.2M | $5.1M | $12.0M | $8.2M |
| Current liabilities | $3.6M | $7.2M | $12.9M | $40.0M | $114M | $61.5M |
| Inventory | $0.5M | $0.2M | $0.0M | $0.0M | $0.2M | $0.1M |
| Property and equipment, net | $18.2M | $24.7M | $22.6M | $24.3M | $100M | $58.3M |
| Goodwill | β | $12.7M | $12.7M | $15.0M | $68.9M | $0.0M |
| Intangible assets | $15.0M | $13.7M | $28.3M | $23.4M | β | β |
| Total assets | $42.3M | $47.7M | $76.3M | $71.2M | $241M | $113M |
| Total liabilities | $16.3M | $20.2M | $49.3M | $54.0M | $126M | $76.3M |
| Preferred stock | β | $0.0M | $0.0M | β | $0.0M | $0.0M |
| Shareholders' equity | $15.4M | $22.5M | $18.9M | $17.2M | $119M | $41.3M |
| Margins | ||||||
| Gross margin | 7.0% | 3.5% | 10.2% | 8.5% | 11.4% | 36.1% |
| Operating margin | β332.6% | β636.3% | β80.9% | β10.7% | β24.5% | β61.1% |
| EBITDA margin | β225.4% | β502.0% | β70.4% | β4.0% | β11.8% | β43.9% |
| Net margin | β197.0% | β666.6% | β72.0% | β18.3% | β29.3% | β105.6% |
| FCF margin | β202.5% | β655.8% | β23.6% | β6.9% | β | β |
| Returns | ||||||
| Return on capital employed | β12.5% | β17.1% | β35.9% | β20.3% | β17.2% | β122.8% |
| Return on equity | β18.6% | β38.2% | β97.8% | β60.1% | β38.6% | β137.3% |
| Return on assets | β6.8% | β16.1% | β32.6% | β14.7% | β16.9% | β62.2% |
| Return on tangible equity | β532.1% | β | β | β | β45.8% | β279.1% |
| Growth | ||||||
| Revenue growth | β | β25.3% | 2,482.4% | 111.1% | 51.4% | 16.3% |
| Share count change | β | β | β | β | β99.2% | 138.1% |
| Financial health | ||||||
| Current ratio | 1.7x | 0.7x | 0.7x | 0.1x | 0.1x | 0.1x |
| Quick ratio | 1.6x | 0.7x | 0.7x | 0.1x | 0.1x | 0.1x |
| Capital allocation | ||||||
| Capex / revenue | 82.2% | 389.2% | 8.9% | 5.6% | β | β |
| Stock comp / revenue | 10.0% | 41.0% | 9.3% | 2.7% | 2.8% | 1.4% |
| Quality scores | ||||||
| Piotroski F-score | β | 1.0 | 3.0 | 3.0 | 5.0 | 4.0 |
| Altman Z'' | β1.7 | β2.5 | β4.3 | β6.5 | β3.6 | β12.2 |
| Accruals ratio | β2.6% | β9.7% | β26.0% | β13.6% | β18.0% | β53.3% |
Source: SEC EDGAR XBRL filings (CIK 0001450704). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.